Risk Factors Associated with Sensorineural Hearing Loss in Infants at the Neonatal Intensive Care Unit: 15-Year Experience at the National Institute of Perinatology (Mexico City)

Archives of Medical Research

Volumn 39, Issue 7, 2008, Pages 686-694

  Martínez Cruz, Carlos Fabián ^a   Poblano, Adrián ^b   Fernández Carrocera, Luis Alberto ^a  

^a INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

^b INSTITUTO NACIONAL DE REHABILITACIÓN   (Mexico)

Author keywords

Brainstem auditory evoked potentials; Neonatal intensive care unit; Newborns; Sensorineural hearing loss

Indexed keywords

BILIRUBIN; LUNG SURFACTANT; STEROID;

ARTICLE; ARTIFICIAL VENTILATION; AUDIOMETRY; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; FOLLOW UP; HIGH RISK INFANT; HOSPITALIZATION; HUMAN; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MEXICO; NEWBORN INTENSIVE CARE; OTOSCOPY; PERCEPTION DEAFNESS; PREVALENCE; PURE TONE AUDIOMETRY; RISK FACTOR; TYMPANOMETRY;

EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; HEARING LOSS, SENSORINEURAL; HEARING TESTS; HUMANS; INFANT; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; MEXICO; RISK FACTORS;

EID: 49949108551     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2008.06.004     Document Type: Article

References (61)

1. Schulman-Galambos C., and Galambos R. Brainstem evoked response audiometry in newborn hearing screening. Arch Otolaryngol 105 (1979) 68-90
2. Doyle L.W., Keir E., Kitchen W.H., Ford G.W., Richards A.L., and Kelly E.A. Audiologic assessment of extremely low birth weight infants: a preliminary report. Pediatrics 90 (1992) 744-749
3. Martínez-Cruz C.F., Poblano A., Fernández-Carrocera L.A., Jiménez-Quiróz R., and Tuyú-Torres N. Association between intelligence quotient scores and extremely low birth weight in school-age children. Arch Med Res 37 (2006) 639-645
4. Joint Committee on Infant Hearing. Year 2000 position statement. Principles and guidelines for early hearing detection and intervention programs. Pediatrics 106 (2000) 798-817
5. Joint Committee on Infant Hearing. Year 2007 position statement. Principles and guidelines for early hearing detection and intervention programs. Pediatrics 120 (2007) 898-921
6. Yoshinaga-Itano C., Sedey A.L., Coulter D.K., and Mehl A.L. Language of early-and later-identified children with hearing loss. Pediatrics 102 (1998) 1161-1171
7. Martínez-Cruz C.F., Fernández-Carrocera L.A., and Osorio-Vázquez M.R. Language screening in school children with sensori-neural hearing loss attended in neonatal intensive care unit (in Spanish). Bol Med Hosp Infant Mex 60 (2003) 398-407
8. Borradori C., Fawer C.L., Buclin T., and Calame A. Risk factors of sensorineural hearing loss in preterm infants. Biol Neonate 71 (1997) 1-10
9. Meyer C., Witte J., Hildmann A., Hennecke K.H., Schunck K.U., Maul K., et al. Neonatal screening for hearing disorders in infants at risk: incidence, risk factors, and follow-up. Pediatrics 104 (1999) 900-904
10. Poblano A., Belmont A., Sosa J., Ibarra J., Vargas A.M., Limon G., et al. Amikacine alters auditory brainstem conduction time in newborns. J Perinat Med 31 (2003) 237-241
11. Chu K., Elimian A., Barbera J., Ogburn P., Spitzer A., and Quirk J.G. Antecedents of newborn hearing loss. Obstet Gynecol 101 (2003) 584-588
12. Bergman I., Hirsch R.P., Fria T.J., Shapiro S.M., Holzman I., and Painter M.J. Cause of hearing loss in the high-risk premature infant. J Pediatr 106 (1985) 95-101
13. Suppiej A., Rizzardi E., Zanardo V., Franzoi M., Ermani M., and Orzan E. Reliability of hearing screening in high-risk neonates: comparative study of otoacoustic emission, automated and conventional auditory brainstem response. Clin Neurophysiol 118 (2007) 869-876
14. Wessex Universal Neonatal Hearing Screening Trial Group. Controlled trial of universal neonatal screening for early identification of permanent childhood hearing impairment. Lancet 352 (1998) 1957-1964
15. Stein L., Ozdamar O., Krauss N., and Paton J. Follow-up of infants screened by auditory brainstem response in the neonatal intensive care. J Pediatr 103 (1983) 447-453
16. Hess M., Finckh-Kramer U., Bartsch M., Kewitz G., Vermold H., and Goss M. Hearing screening in at-risk neonate cohort. Int J Pediatr Otorhinolaryngol 46 (1998) 81-89
17. Kemper A.R., and Downs S.M. A cost-effectiveness analysis of newborn hearing screening strategies. Arch Pediatr Adolesc Med 155 (2001) 421-422
18. Nagapoornima P., Ramesh A., Srilakshmi R.S., Patricia P.L., Gore M., et al. Universal hearing screening. Indian J Pediatr 74 (2007) 545-549
19. Harrison W.A., Dunnell J.J., Mascher K., Fletcher K., Vohr B.R., Gorga M.P., et al. Identification of neonatal hearing impairment: experimental protocol and database management. Ear Hear 21 (2000) 357-372
20. Hess M., Finckh-Krämer U., Bartsch M., Kewitz G., Versmold H., and Gross M. Hearing screening in at-risk neonate cohort. Int J Pediatr Otorhinolaryngol 15 (1998) 81-89
21. Norton S.J., Gorga M.P., Widen J.E., Folsom R.C., Sininger Y., Cone-Wesson B., et al. Identification of neonatal hearing impairment: a multicenter investigation. Ear Hear 21 (2000) 348-356
22. Jiang Z.D., Wang J., Brosi D.M., Shao X.M., and Wilkinson A.R. One-third of term babies after perinatal hypoxia-ischaemia have transient hearing impairment: dynamic change in hearing threshold during the neonatal period. Acta Paediatr 93 (2004) 82-87
23. Silver S., Kapitulnik J., and Sohmer H. Contribution to asphyxia to the induction of hearing impairment in jaundice Gunn rats. Pediatrics 95 (1995) 579-583
24. Watchko J.F., and Maisels M.J. Jaundice in low birthweight infants: pathobiology and outcome. Arch Dis Child Fetal Neonatol Ed 88 (2003) F455-F458
25. Ogün B., Serbetcioglü B., Duman O.H., and Kirkim G. Long-term outcome of neonatal hyperbilirubinaemia: subjective and objective audiological measures. Clin Otolaryngol 28 (2003) 507-513
26. Ostrow J.D., Pascolo L., Shapiro S.M., and Tiribelli C. New concepts in bilirubin encephalopathy. Eur J Clin Invest 33 (2003) 988-997
27. de Vries L.S., Lary S., and Dubowitz L.M.S. Relationship of serum bilirubin levels to ototoxicity and deafness in high-risk low-birth-weight infants. Pediatrics 76 (1985) 351-354
28. Shapiro S.M. Bilirubin toxicity in the developing nervous system. Pediatr Neurol 29 (2003) 410-421
29. Garza-Morales S., Poblano A., Robledo-Galvan A., and Fernandez-Carrocera L.A. Auditory evoked potentials in children with neonatal risk for hypoacusis. Pan Am J Public Health 2 (1997) 232-237
30. Wu W.J., Sha S.H., and Schacht J. Recent advances in understanding aminoglycoside ototoxicity and its prevention. Audiol Neurootol 7 (2002) 171-174
31. de Hoog M., van Zanten B.A., Hop W.C., Overbosch E., and Weisglas-Kuperus N. van der Anker JM. Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss. J Pediatr 142 (2003) 41-46
32. Fischel G.M., Prezant T.R., Bu X., and Oztas S. Mitochondrial ribosomal RNA gene mutation in patient with sporadic aminoglucoside ototoxicity. Am J Otolaryngol 14 (1993) 399-403
33. Ruggieri-Marone M., and Schochat E. Distortion product otoacoustic emissions in newborns treated by ototoxic drugs (in French). Rev Laryngol Otol Rynol (Bord) 128 (2007) 41-46
34. Rais-Bahrami K., Majd M., Veszelovszky E., and Short B. Use of furosemide and hearing loss in neonatal intensive care survivors. Am J Perinatol 21 (2004) 329-332
35. Rybak L.P., Whitworth C., Scott V., and Weberg A. Ototoxicity of furosemide during development. Laryngoscope 101 (1991) 1167-1174
36. Brown D.R., Watchko J.F., and Sabo D. Neonatal sensorineural hearing loss associated with furosemide: a case-control study. Dev Med Child Neurol 33 (1991) 816-823
37. Williams D.P., Antoine D.J., Butler P.J., Jones R., Randle L.E., Payne A., et al. The metabolism and toxicity of furosemide in the Wistar rat and CD-1 mouse: a chemical and biochemical definition of the toxicophore. J Pharmacol Exp Ther 322 (2007) 1208-1220
38. Spector G.J., Pettit W.J., Davis G., Strauss M., and Rauchbach E. Fetal respiratory distress causing CNS and inner ear hemorrhage. Laryngoscope 88 (1978) 764-784
39. Vohr B.R., Allan W.C., Westerveld M., Schneider K.C., Katz K.H., Makuch R.W., et al. School-age outcomes of very low birth weight infants in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 111 (2003) 340-346
40. Bedford H., de Louvois J., Halket S., Peckham C., Hurley R., and Harvey D. Meningitis in England and Wales: follow up at 5 years. BMJ 323 (2001) 1-5
41. Fujiwara S., Yang L., Waffarn F., and Lerner M. Persistent pulmonary hypertension of the newborn (PPHN) treated with inhaled nitric oxide: preliminary hearing outcomes. J Am Acad Audiol 8 (1997) 263-268
42. Lipkin P.H., Davidson D., Spivak L., Straube R., Rhines J., and Chang C.T. Neurodevelopment and medical outcomes of persistent pulmonary hypertension in term newborn treated with nitric oxide. J Pediatr 140 (2002) 306-310
43. Papile L.A., Burstein J., Burstein R., and Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 gm. J Pediatr 92 (1978) 529-534
44. Martínez-Cruz C.F., and Fernández-Carrocera L.A. Audiologic examination of very low birth weight infant (in Spanish). Bol Med Hosp Infant Mex 58 (2001) 843-853
45. Poblano A., Chayo I., Ibarra J., and Rueda E. Electrophysiologic and behavioral methods in early detection of hearing impairment. Arch Med Res 31 (2000) 75-80
46. Buren M., Solem B.S., and Laukli E. Threshold of hearing (0.125-20 kHz) in children and youngsters. Br J Audiol 26 (1992) 23-31
47. Stephens D. Audiological terms. In: Martini A. (Ed). Definitions, protocols and guidelines in genetic hearing imparirment (2001), Whurr Publishers, London 9-16
48. Camacho-Rosales J. Statistics with SPSS for Windows (in Spanish) (2001), Alfa-omega, Madrid
49. Genetics Evaluation of Congenital Hearing Loss Expert Panel. Genetics evaluation guidelines for etiological diagnosis of congenital hearing loss. Genet Med 4 (2002) 162-171
50. Yee-Arellano H.M., Leal-Garza F., and Pauli-Müller J. Universal newborn hearing screening in Mexico: results of the first 2 years. Int J Pediat Otorhinolaryngol 70 (2006) 1863-1870
51. Peñaloza-López Y., Castillo-Maya G., García-Pedroza F., and Sánchez-López H. Hypoacusis-deafness related to perinatal adverse conditions according to the register available in a specialized unit of Mexico City. Analysis according to birth weight. Acta Otorrinolaringol Esp 55 (2004) 252-259
52. Xionis K., Weirather Y., Mavoori H., Shaha S.H., and Iwamoto L.M. Extremely low birth weight infants are at high risk for auditory neuropathy. J Perinatol 27 (2007) 718-723
53. Wu C.C., Chiu Y.H., Chen P.J., and Hsu C.J. Prevalence and clinical features of the mitochondrial m.1555A>G mutation in Taiwanese patients with idiopathic sensorineural hearing loss and association of haplogroup F with low penetrance in three families. Ear Hear 28 (2007) 332-342
54. Sanjay M., Westerberg B.D., and Kozak F.K. Systematic review of the etiology of bilateral sensorineural hearing loss in children. Int J Pediatr Otorhinolaryngol 68 (2004) 1193-1198
55. Smith R.J.H., Bale J.F., and White K.R. Sensorineural hearing loss in children. Lancet 365 (2005) 879-890
56. Bess F.H., Dodd-Murphy J., and Parker R.A. Children with minimal sensorineural hearing loss: prevalence, educational performance, and functional status. Ear Hear 19 (1998) 339-354
57. Cone-Wesson B., and Rance G. Auditory neuropathy: a brief review. Otolaryngol Head Neck Surg 8 (2000) 421-425
58. Rance G., Cone-Wesson B., Wunderlich J., and Dowell R. Speech perception and cortical event related potentials in children with auditory neuropathy. Ear Hear 23 (2002) 239-253
59. Foerst A., Beutner D., Lang-Roth R., Huttenbrink K.B., von Welden H., and Walger M. Prevalence of auditory neuropathy/synaptopathy in a population of children with profound hearing loss. Int J Pediatr Otorhinolaryngol 70 (2006) 1415-1422
60. Rance G., and Barker E.J. Speech perception in children with auditory/dyssynchrony managed with either hearing aids or cochlear implants. Otol Neurotol 29 (2008) 179-182
61. Martínez-Cruz C.F., and Ramírez-Vargas N.M. Bilateral deafness secondary to adverse factors during the neonatal period (in Spanish). An ORL Mex 48 (2003) 62-69